The American Bar
Association (ABA) Section of Intellectual Property Law, Young Lawyers Action
Division, Young Lawyers Division, and Center for Professional Development will
be offering a live webinar on "The
Nuts & Bolts of Patents and the Drug Approval Process" on November
14, 2013 from 1:00 to 2:30 pm (Eastern).
Dr. Keisha Hylton-Rodic of the Nevrivy Patent Law Group will
moderate a panel consisting of Ali. I.
Ahmed, Chief Intellectual Property Counsel, Fresenius Kabi USA, LLC; James
N. Czaban of Wiley Rein LLP;
and Len Smith, Vice President,
Intellectual Property Counsel, Medicis. The panel will examine the basics of the
Hatch-Waxman drug approval process, and discuss what IP attorneys need to know
in order to work effectively with regulatory counsel and to navigate the
approval process. The panel will also
examine what is involved in filing a new drug application (NDA), ANDA,
505(b)(2) application, and BLA.
The registration fee for
the webcast is $95 for members of any of the sections sponsoring the webinar,
$99 for government attorneys, $150 for ABA members, and $195 for the general
public. Those interested in registering
for the webinar, can do so here
or by calling 800-285-2221.
Comments